Integra Lifesciences Holdings (IART) Operating Income (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Operating Income of $19.3 million for Q2 2026, up 68.13% sequentially from $11.5 million in Q1 2026, and up 103.76% YoY from $9.5 million in Q2 2025.
Integra Lifesciences Holdings (IART) Operating Income (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Operating Income for 18 years, with the latest figure at $19.3 million in Q2 2026.
- Quarterly Operating Income rose 103.76% year-over-year to $19.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $65.6 million (up 113.09% YoY) and the FY2025 annual result came in at -$493.4 million, down 1836.55% from the prior year.
- Operating Income rose to $19.3 million in Q2 2026 per IART's latest filing, from $11.5 million in the prior quarter.
- Over five years, Operating Income peaked at $67.8 million in Q4 2022 and troughed at -$512.7 million in Q2 2025.
- A 5-year average of -$4.7 million and a median of $21.2 million in 2025 frame the typical range for Operating Income.
- The widest YoY moves for Operating Income: up 244.31% in 2025, down 16825.52% in 2025.
- Over 5 years, Operating Income stood at $67.8 million in 2022, then tumbled by 46.86% to $36.0 million in 2023, then dropped by 1.17% to $35.6 million in 2024, then slumped by 35.33% to $23.0 million in 2025, then decreased by 16.3% to $19.3 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $19.3 million, $11.5 million, and $23.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Integra Lifesciences Holdings | 1.30 Bn | 1.02 Bn | 219.74 Mn | 19.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.29 Mn |
| Mar 31, 2026 | 11.47 Mn |
| Dec 31, 2025 | 23.04 Mn |
| Sep 30, 2025 | 11.76 Mn |
| Jun 30, 2025 | -512.67 Mn |
| Mar 31, 2025 | -15.50 Mn |
| Dec 31, 2024 | 35.63 Mn |
| Sep 30, 2024 | -8.15 Mn |
| Jun 30, 2024 | -3.03 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Dec 31, 2023 | 36.05 Mn |
| Sep 30, 2023 | 26.59 Mn |
| Jun 30, 2023 | 12.50 Mn |
| Mar 31, 2023 | 36.38 Mn |
| Dec 31, 2022 | 67.84 Mn |
| Sep 30, 2022 | 65.05 Mn |
| Jun 30, 2022 | 59.87 Mn |
| Mar 31, 2022 | 46.16 Mn |
| Dec 31, 2021 | 58.22 Mn |
| Sep 30, 2021 | 56.44 Mn |